Apr 22 |
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
|
Mar 29 |
Why Is Editas (EDIT) Down 26.2% Since Last Earnings Report?
|
Mar 26 |
Biotech Roundtable: Is CRISPR all it's cracked up to be?
|
Mar 13 |
Editas Medicine, Inc. (EDIT) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)
|
Mar 12 |
Editas Medicine, Inc. (EDIT) Leerink Partners Global Biopharma Conference (Transcript)
|
Mar 7 |
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
|
Mar 6 |
Editas Medicine, Inc. (EDIT) TD Cowen 44th Annual Healthcare Conference (Transcript)
|
Mar 6 |
Insider Sells Shares of Editas Medicine Inc (EDIT)
|
Mar 4 |
1 Beaten-Down Stock With 55% Upside, According to Wall Street
|
Mar 3 |
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
|